218 related articles for article (PubMed ID: 25227751)
1. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Zhang C; Wang H; Nie J; Wang F
Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
4. New treatments for diabetic retinopathy.
Das A; Stroud S; Mehta A; Rangasamy S
Diabetes Obes Metab; 2015 Mar; 17(3):219-30. PubMed ID: 25160598
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
6. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
[TBL] [Abstract][Full Text] [Related]
7. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
[TBL] [Abstract][Full Text] [Related]
8. VIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema.
Maugeri G; D'Amico AG; Gagliano C; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Physiol; 2017 May; 232(5):1079-1085. PubMed ID: 27486932
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
Garcia-Ramírez M; Hernández C; Palomer X; Vázquez-Carrera M; Simó R
Acta Diabetol; 2016 Feb; 53(1):109-18. PubMed ID: 25936740
[TBL] [Abstract][Full Text] [Related]
10. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiology and therapeutic progress of diabetic macular edema].
Li B; Ye JJ
Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):625-630. PubMed ID: 30107656
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
Wang L; Wang N; Tan HY; Zhang Y; Feng Y
J Ethnopharmacol; 2015 Jul; 169():295-304. PubMed ID: 25929449
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
Felinski EA; Antonetti DA
Curr Eye Res; 2005 Nov; 30(11):949-57. PubMed ID: 16282129
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
Das A; McGuire PG; Monickaraj F
Indian J Ophthalmol; 2016 Jan; 64(1):4-13. PubMed ID: 26953018
[TBL] [Abstract][Full Text] [Related]
15. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
[TBL] [Abstract][Full Text] [Related]
16. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.
Rudraraju M; Narayanan SP; Somanath PR
Pharmacol Res; 2020 Nov; 161():105115. PubMed ID: 32750417
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
[TBL] [Abstract][Full Text] [Related]
18. NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression.
D'Amico AG; Maugeri G; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Physiol; 2018 Feb; 233(2):1120-1128. PubMed ID: 28436035
[TBL] [Abstract][Full Text] [Related]
19. Blood-retinal barrier.
Cunha-Vaz J; Bernardes R; Lobo C
Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Retinal Fluid Accumulation and Blood-Retinal Barrier Breakdown.
Cunha-Vaz J
Dev Ophthalmol; 2017; 58():11-20. PubMed ID: 28351041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
